Less Ads, More Data, More Tools Register for FREE

Appointment of Joint Broker

5 Mar 2025 07:00

RNS Number : 3455Z
Target Healthcare REIT PLC
05 March 2025
 

5 March 2025

Target Healthcare REIT plc and its subsidiaries

("Target Healthcare" or "the Group")

Appointment of Joint Broker

 

Target Healthcare (LSE: THRL), the UK listed specialist investor in modern, purpose-built care homes, is pleased to announce the appointment of Panmure Liberum Limited ("Panmure Liberum") as joint broker, to work alongside Stifel Nicolaus Europe Limited, the Group's existing corporate broker, with immediate effect. 

 

LEI: 213800RXPY9WULUSBC04

 

For further information, please contact:

Target Fund Managers Limited

Tel: 01786 845 912

Kenneth MacKenzie

Gordon Bland

 

 

 

 

Stifel Nicolaus Europe Limited

Tel: 020 7710 7600

Mark Young

Rajpal Padam

Catriona Neville

 

 

 

Panmure Liberum Limited

Tel: 020 3100 2000

Jamie Richards

David Watkins

Nikhil Varghese

  Dougie McLeod

 

 

 

FTI Consulting

Tel: 020 3727 1000

Dido Laurimore

Richard Gotla

 

TargetHealthcare@fticonsulting.com

 

 

Notes to editors:

UK listed Target Healthcare REIT plc (THRL) is an externally managed Real Estate Investment Trust which provides shareholders with an attractive level of income, together with the potential for capital and income growth, from investing in a diversified portfolio of modern, purpose-built care homes.

The Group's portfolio at 31 December 2024 comprised 94 assets let to 34 tenants with a total value of £924.7 million.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
APPDZLFBEXLFBBD

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS